Global Anti-Nuclear Radiation Drug Supply, Demand and Key Producers, 2023-2029
The global Anti-Nuclear Radiation Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The development prospect of anti-nuclear radiation medicine depends to a large extent on the development trend of global nuclear energy. If the global nuclear power generation continues to increase, the market demand for nuclear radiation protection drugs may increase accordingly.
At present, the global anti-nuclear radiation drug market has been researched and developed by some major pharmaceutical companies and biotechnology companies. The main types of anti-nuclear radiation drugs include stable iodine, Prussian blue, zinc lozenges, complement activators, antibiotics, anti-radiation drugs, etc. Among them, stable iodine and Prussian blue are the most commonly used drugs for the prevention and treatment of acute radiation exposure.
Although the market size of nuclear radiation protection drugs is relatively small, it is expected to maintain rapid growth in the coming years. This is primarily attributable to heightened concern over nuclear radiation incidents and increased need for prevention and treatment of radiation exposure.
However, the development and application of anti-nuclear radiation drugs still face some challenges. For example, anti-nuclear radiation drugs currently on the market are mainly aimed at a specific type or dose of radiation, rather than being widely applicable. In addition, due to the rarity of nuclear radiation incidents, there are certain difficulties in clinical trials and applications of these drugs.
In general, the development prospects of anti-nuclear radiation drugs seem bright, but continued in-depth research and development are needed to overcome existing technical and market challenges.
Nuclear radiation refers to the various microscopic particles and electromagnetic radiation or energy released during nuclear reactions such as fission and decay of atomic nuclei. This kind of radioactive material exists in large quantities in nuclear explosions, nuclear leakage accidents and nuclear waste. Anti-nuclear radiation drugs commonly used in clinical practice include thiol drugs, cytokine drugs, hormone drugs, metal complexing agents, and Chinese herbal medicines.
This report studies the global Anti-Nuclear Radiation Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Anti-Nuclear Radiation Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-Nuclear Radiation Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Anti-Nuclear Radiation Drug total production and demand, 2018-2029, (K Units)
Global Anti-Nuclear Radiation Drug total production value, 2018-2029, (USD Million)
Global Anti-Nuclear Radiation Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Anti-Nuclear Radiation Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Anti-Nuclear Radiation Drug domestic production, consumption, key domestic manufacturers and share
Global Anti-Nuclear Radiation Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Anti-Nuclear Radiation Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Anti-Nuclear Radiation Drug production by Sales Channel production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Anti-Nuclear Radiation Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Humanwell Healthcare, Jiangsu Wuzhong Pharmaceutical Group, Hisun Pharmaceutical, Beijing Centergate Technologies, Lisheng Pharmaceutical, Bayer AG, GlaxoSmithKline and Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-Nuclear Radiation Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Sales Channel. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Anti-Nuclear Radiation Drug Market, By Region:
1. How big is the global Anti-Nuclear Radiation Drug market?
2. What is the demand of the global Anti-Nuclear Radiation Drug market?
3. What is the year over year growth of the global Anti-Nuclear Radiation Drug market?
4. What is the production and production value of the global Anti-Nuclear Radiation Drug market?
5. Who are the key producers in the global Anti-Nuclear Radiation Drug market?
The development prospect of anti-nuclear radiation medicine depends to a large extent on the development trend of global nuclear energy. If the global nuclear power generation continues to increase, the market demand for nuclear radiation protection drugs may increase accordingly.
At present, the global anti-nuclear radiation drug market has been researched and developed by some major pharmaceutical companies and biotechnology companies. The main types of anti-nuclear radiation drugs include stable iodine, Prussian blue, zinc lozenges, complement activators, antibiotics, anti-radiation drugs, etc. Among them, stable iodine and Prussian blue are the most commonly used drugs for the prevention and treatment of acute radiation exposure.
Although the market size of nuclear radiation protection drugs is relatively small, it is expected to maintain rapid growth in the coming years. This is primarily attributable to heightened concern over nuclear radiation incidents and increased need for prevention and treatment of radiation exposure.
However, the development and application of anti-nuclear radiation drugs still face some challenges. For example, anti-nuclear radiation drugs currently on the market are mainly aimed at a specific type or dose of radiation, rather than being widely applicable. In addition, due to the rarity of nuclear radiation incidents, there are certain difficulties in clinical trials and applications of these drugs.
In general, the development prospects of anti-nuclear radiation drugs seem bright, but continued in-depth research and development are needed to overcome existing technical and market challenges.
Nuclear radiation refers to the various microscopic particles and electromagnetic radiation or energy released during nuclear reactions such as fission and decay of atomic nuclei. This kind of radioactive material exists in large quantities in nuclear explosions, nuclear leakage accidents and nuclear waste. Anti-nuclear radiation drugs commonly used in clinical practice include thiol drugs, cytokine drugs, hormone drugs, metal complexing agents, and Chinese herbal medicines.
This report studies the global Anti-Nuclear Radiation Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Anti-Nuclear Radiation Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-Nuclear Radiation Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Anti-Nuclear Radiation Drug total production and demand, 2018-2029, (K Units)
Global Anti-Nuclear Radiation Drug total production value, 2018-2029, (USD Million)
Global Anti-Nuclear Radiation Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Anti-Nuclear Radiation Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Anti-Nuclear Radiation Drug domestic production, consumption, key domestic manufacturers and share
Global Anti-Nuclear Radiation Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Anti-Nuclear Radiation Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Anti-Nuclear Radiation Drug production by Sales Channel production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Anti-Nuclear Radiation Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Humanwell Healthcare, Jiangsu Wuzhong Pharmaceutical Group, Hisun Pharmaceutical, Beijing Centergate Technologies, Lisheng Pharmaceutical, Bayer AG, GlaxoSmithKline and Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-Nuclear Radiation Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Sales Channel. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Anti-Nuclear Radiation Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Potassium Iodide (KI)
- Prussian Blue
- Diethylenetriamine Pentaacetate (DTPA)
- Filgrastim
- Amifostine
- Ex-Rad
- Online Sales
- Offline Sales
- Amgen
- Humanwell Healthcare
- Jiangsu Wuzhong Pharmaceutical Group
- Hisun Pharmaceutical
- Beijing Centergate Technologies
- Lisheng Pharmaceutical
- Bayer AG
- GlaxoSmithKline
- Pfizer
- Onconova
- Novartis AG
- Teva Pharmaceuticals
- Clinigen
- Sun Pharmaceutical
- Taj Pharmaceuticals
- Merro Pharmaceutical
- Luye Pharma
- Mingren Pharma
- Gilead Sciences
- Johnson & Johnson
- Merck KGaA
- Genentech Inc.
1. How big is the global Anti-Nuclear Radiation Drug market?
2. What is the demand of the global Anti-Nuclear Radiation Drug market?
3. What is the year over year growth of the global Anti-Nuclear Radiation Drug market?
4. What is the production and production value of the global Anti-Nuclear Radiation Drug market?
5. Who are the key producers in the global Anti-Nuclear Radiation Drug market?
1 SUPPLY SUMMARY
1.1 Anti-Nuclear Radiation Drug Introduction
1.2 World Anti-Nuclear Radiation Drug Supply & Forecast
1.2.1 World Anti-Nuclear Radiation Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Anti-Nuclear Radiation Drug Production (2018-2029)
1.2.3 World Anti-Nuclear Radiation Drug Pricing Trends (2018-2029)
1.3 World Anti-Nuclear Radiation Drug Production by Region (Based on Production Site)
1.3.1 World Anti-Nuclear Radiation Drug Production Value by Region (2018-2029)
1.3.2 World Anti-Nuclear Radiation Drug Production by Region (2018-2029)
1.3.3 World Anti-Nuclear Radiation Drug Average Price by Region (2018-2029)
1.3.4 North America Anti-Nuclear Radiation Drug Production (2018-2029)
1.3.5 Europe Anti-Nuclear Radiation Drug Production (2018-2029)
1.3.6 China Anti-Nuclear Radiation Drug Production (2018-2029)
1.3.7 Japan Anti-Nuclear Radiation Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Anti-Nuclear Radiation Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Anti-Nuclear Radiation Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Anti-Nuclear Radiation Drug Demand (2018-2029)
2.2 World Anti-Nuclear Radiation Drug Consumption by Region
2.2.1 World Anti-Nuclear Radiation Drug Consumption by Region (2018-2023)
2.2.2 World Anti-Nuclear Radiation Drug Consumption Forecast by Region (2024-2029)
2.3 United States Anti-Nuclear Radiation Drug Consumption (2018-2029)
2.4 China Anti-Nuclear Radiation Drug Consumption (2018-2029)
2.5 Europe Anti-Nuclear Radiation Drug Consumption (2018-2029)
2.6 Japan Anti-Nuclear Radiation Drug Consumption (2018-2029)
2.7 South Korea Anti-Nuclear Radiation Drug Consumption (2018-2029)
2.8 ASEAN Anti-Nuclear Radiation Drug Consumption (2018-2029)
2.9 India Anti-Nuclear Radiation Drug Consumption (2018-2029)
3 WORLD ANTI-NUCLEAR RADIATION DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Anti-Nuclear Radiation Drug Production Value by Manufacturer (2018-2023)
3.2 World Anti-Nuclear Radiation Drug Production by Manufacturer (2018-2023)
3.3 World Anti-Nuclear Radiation Drug Average Price by Manufacturer (2018-2023)
3.4 Anti-Nuclear Radiation Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Anti-Nuclear Radiation Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Anti-Nuclear Radiation Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Anti-Nuclear Radiation Drug in 2022
3.6 Anti-Nuclear Radiation Drug Market: Overall Company Footprint Analysis
3.6.1 Anti-Nuclear Radiation Drug Market: Region Footprint
3.6.2 Anti-Nuclear Radiation Drug Market: Company Product Type Footprint
3.6.3 Anti-Nuclear Radiation Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Anti-Nuclear Radiation Drug Production Value Comparison
4.1.1 United States VS China: Anti-Nuclear Radiation Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Anti-Nuclear Radiation Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Anti-Nuclear Radiation Drug Production Comparison
4.2.1 United States VS China: Anti-Nuclear Radiation Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Anti-Nuclear Radiation Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Anti-Nuclear Radiation Drug Consumption Comparison
4.3.1 United States VS China: Anti-Nuclear Radiation Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Anti-Nuclear Radiation Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Anti-Nuclear Radiation Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Anti-Nuclear Radiation Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Anti-Nuclear Radiation Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Anti-Nuclear Radiation Drug Production (2018-2023)
4.5 China Based Anti-Nuclear Radiation Drug Manufacturers and Market Share
4.5.1 China Based Anti-Nuclear Radiation Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Anti-Nuclear Radiation Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Anti-Nuclear Radiation Drug Production (2018-2023)
4.6 Rest of World Based Anti-Nuclear Radiation Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Anti-Nuclear Radiation Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Anti-Nuclear Radiation Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Potassium Iodide (KI)
5.2.2 Prussian Blue
5.2.3 Diethylenetriamine Pentaacetate (DTPA)
5.2.4 Filgrastim
5.2.5 Amifostine
5.2.6 Ex-Rad
5.3 Market Segment by Type
5.3.1 World Anti-Nuclear Radiation Drug Production by Type (2018-2029)
5.3.2 World Anti-Nuclear Radiation Drug Production Value by Type (2018-2029)
5.3.3 World Anti-Nuclear Radiation Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY SALES CHANNEL
6.1 World Anti-Nuclear Radiation Drug Market Size Overview by Sales Channel: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Sales Channel
6.2.1 Online Sales
6.2.2 Offline Sales
6.3 Market Segment by Sales Channel
6.3.1 World Anti-Nuclear Radiation Drug Production by Sales Channel (2018-2029)
6.3.2 World Anti-Nuclear Radiation Drug Production Value by Sales Channel (2018-2029)
6.3.3 World Anti-Nuclear Radiation Drug Average Price by Sales Channel (2018-2029)
7 COMPANY PROFILES
7.1 Amgen
7.1.1 Amgen Details
7.1.2 Amgen Major Business
7.1.3 Amgen Anti-Nuclear Radiation Drug Product and Services
7.1.4 Amgen Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Amgen Recent Developments/Updates
7.1.6 Amgen Competitive Strengths & Weaknesses
7.2 Humanwell Healthcare
7.2.1 Humanwell Healthcare Details
7.2.2 Humanwell Healthcare Major Business
7.2.3 Humanwell Healthcare Anti-Nuclear Radiation Drug Product and Services
7.2.4 Humanwell Healthcare Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Humanwell Healthcare Recent Developments/Updates
7.2.6 Humanwell Healthcare Competitive Strengths & Weaknesses
7.3 Jiangsu Wuzhong Pharmaceutical Group
7.3.1 Jiangsu Wuzhong Pharmaceutical Group Details
7.3.2 Jiangsu Wuzhong Pharmaceutical Group Major Business
7.3.3 Jiangsu Wuzhong Pharmaceutical Group Anti-Nuclear Radiation Drug Product and Services
7.3.4 Jiangsu Wuzhong Pharmaceutical Group Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Jiangsu Wuzhong Pharmaceutical Group Recent Developments/Updates
7.3.6 Jiangsu Wuzhong Pharmaceutical Group Competitive Strengths & Weaknesses
7.4 Hisun Pharmaceutical
7.4.1 Hisun Pharmaceutical Details
7.4.2 Hisun Pharmaceutical Major Business
7.4.3 Hisun Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
7.4.4 Hisun Pharmaceutical Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Hisun Pharmaceutical Recent Developments/Updates
7.4.6 Hisun Pharmaceutical Competitive Strengths & Weaknesses
7.5 Beijing Centergate Technologies
7.5.1 Beijing Centergate Technologies Details
7.5.2 Beijing Centergate Technologies Major Business
7.5.3 Beijing Centergate Technologies Anti-Nuclear Radiation Drug Product and Services
7.5.4 Beijing Centergate Technologies Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Beijing Centergate Technologies Recent Developments/Updates
7.5.6 Beijing Centergate Technologies Competitive Strengths & Weaknesses
7.6 Lisheng Pharmaceutical
7.6.1 Lisheng Pharmaceutical Details
7.6.2 Lisheng Pharmaceutical Major Business
7.6.3 Lisheng Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
7.6.4 Lisheng Pharmaceutical Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Lisheng Pharmaceutical Recent Developments/Updates
7.6.6 Lisheng Pharmaceutical Competitive Strengths & Weaknesses
7.7 Bayer AG
7.7.1 Bayer AG Details
7.7.2 Bayer AG Major Business
7.7.3 Bayer AG Anti-Nuclear Radiation Drug Product and Services
7.7.4 Bayer AG Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bayer AG Recent Developments/Updates
7.7.6 Bayer AG Competitive Strengths & Weaknesses
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Details
7.8.2 GlaxoSmithKline Major Business
7.8.3 GlaxoSmithKline Anti-Nuclear Radiation Drug Product and Services
7.8.4 GlaxoSmithKline Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 GlaxoSmithKline Recent Developments/Updates
7.8.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.9 Pfizer
7.9.1 Pfizer Details
7.9.2 Pfizer Major Business
7.9.3 Pfizer Anti-Nuclear Radiation Drug Product and Services
7.9.4 Pfizer Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Pfizer Recent Developments/Updates
7.9.6 Pfizer Competitive Strengths & Weaknesses
7.10 Onconova
7.10.1 Onconova Details
7.10.2 Onconova Major Business
7.10.3 Onconova Anti-Nuclear Radiation Drug Product and Services
7.10.4 Onconova Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Onconova Recent Developments/Updates
7.10.6 Onconova Competitive Strengths & Weaknesses
7.11 Novartis AG
7.11.1 Novartis AG Details
7.11.2 Novartis AG Major Business
7.11.3 Novartis AG Anti-Nuclear Radiation Drug Product and Services
7.11.4 Novartis AG Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Novartis AG Recent Developments/Updates
7.11.6 Novartis AG Competitive Strengths & Weaknesses
7.12 Teva Pharmaceuticals
7.12.1 Teva Pharmaceuticals Details
7.12.2 Teva Pharmaceuticals Major Business
7.12.3 Teva Pharmaceuticals Anti-Nuclear Radiation Drug Product and Services
7.12.4 Teva Pharmaceuticals Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Teva Pharmaceuticals Recent Developments/Updates
7.12.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.13 Clinigen
7.13.1 Clinigen Details
7.13.2 Clinigen Major Business
7.13.3 Clinigen Anti-Nuclear Radiation Drug Product and Services
7.13.4 Clinigen Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Clinigen Recent Developments/Updates
7.13.6 Clinigen Competitive Strengths & Weaknesses
7.14 Sun Pharmaceutical
7.14.1 Sun Pharmaceutical Details
7.14.2 Sun Pharmaceutical Major Business
7.14.3 Sun Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
7.14.4 Sun Pharmaceutical Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Sun Pharmaceutical Recent Developments/Updates
7.14.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
7.15 Taj Pharmaceuticals
7.15.1 Taj Pharmaceuticals Details
7.15.2 Taj Pharmaceuticals Major Business
7.15.3 Taj Pharmaceuticals Anti-Nuclear Radiation Drug Product and Services
7.15.4 Taj Pharmaceuticals Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Taj Pharmaceuticals Recent Developments/Updates
7.15.6 Taj Pharmaceuticals Competitive Strengths & Weaknesses
7.16 Merro Pharmaceutical
7.16.1 Merro Pharmaceutical Details
7.16.2 Merro Pharmaceutical Major Business
7.16.3 Merro Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
7.16.4 Merro Pharmaceutical Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Merro Pharmaceutical Recent Developments/Updates
7.16.6 Merro Pharmaceutical Competitive Strengths & Weaknesses
7.17 Luye Pharma
7.17.1 Luye Pharma Details
7.17.2 Luye Pharma Major Business
7.17.3 Luye Pharma Anti-Nuclear Radiation Drug Product and Services
7.17.4 Luye Pharma Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Luye Pharma Recent Developments/Updates
7.17.6 Luye Pharma Competitive Strengths & Weaknesses
7.18 Mingren Pharma
7.18.1 Mingren Pharma Details
7.18.2 Mingren Pharma Major Business
7.18.3 Mingren Pharma Anti-Nuclear Radiation Drug Product and Services
7.18.4 Mingren Pharma Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Mingren Pharma Recent Developments/Updates
7.18.6 Mingren Pharma Competitive Strengths & Weaknesses
7.19 Gilead Sciences
7.19.1 Gilead Sciences Details
7.19.2 Gilead Sciences Major Business
7.19.3 Gilead Sciences Anti-Nuclear Radiation Drug Product and Services
7.19.4 Gilead Sciences Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Gilead Sciences Recent Developments/Updates
7.19.6 Gilead Sciences Competitive Strengths & Weaknesses
7.20 Johnson & Johnson
7.20.1 Johnson & Johnson Details
7.20.2 Johnson & Johnson Major Business
7.20.3 Johnson & Johnson Anti-Nuclear Radiation Drug Product and Services
7.20.4 Johnson & Johnson Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Johnson & Johnson Recent Developments/Updates
7.20.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.21 Merck KGaA
7.21.1 Merck KGaA Details
7.21.2 Merck KGaA Major Business
7.21.3 Merck KGaA Anti-Nuclear Radiation Drug Product and Services
7.21.4 Merck KGaA Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 Merck KGaA Recent Developments/Updates
7.21.6 Merck KGaA Competitive Strengths & Weaknesses
7.22 Genentech Inc.
7.22.1 Genentech Inc. Details
7.22.2 Genentech Inc. Major Business
7.22.3 Genentech Inc. Anti-Nuclear Radiation Drug Product and Services
7.22.4 Genentech Inc. Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 Genentech Inc. Recent Developments/Updates
7.22.6 Genentech Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Anti-Nuclear Radiation Drug Industry Chain
8.2 Anti-Nuclear Radiation Drug Upstream Analysis
8.2.1 Anti-Nuclear Radiation Drug Core Raw Materials
8.2.2 Main Manufacturers of Anti-Nuclear Radiation Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Anti-Nuclear Radiation Drug Production Mode
8.6 Anti-Nuclear Radiation Drug Procurement Model
8.7 Anti-Nuclear Radiation Drug Industry Sales Model and Sales Channels
8.7.1 Anti-Nuclear Radiation Drug Sales Model
8.7.2 Anti-Nuclear Radiation Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Anti-Nuclear Radiation Drug Introduction
1.2 World Anti-Nuclear Radiation Drug Supply & Forecast
1.2.1 World Anti-Nuclear Radiation Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Anti-Nuclear Radiation Drug Production (2018-2029)
1.2.3 World Anti-Nuclear Radiation Drug Pricing Trends (2018-2029)
1.3 World Anti-Nuclear Radiation Drug Production by Region (Based on Production Site)
1.3.1 World Anti-Nuclear Radiation Drug Production Value by Region (2018-2029)
1.3.2 World Anti-Nuclear Radiation Drug Production by Region (2018-2029)
1.3.3 World Anti-Nuclear Radiation Drug Average Price by Region (2018-2029)
1.3.4 North America Anti-Nuclear Radiation Drug Production (2018-2029)
1.3.5 Europe Anti-Nuclear Radiation Drug Production (2018-2029)
1.3.6 China Anti-Nuclear Radiation Drug Production (2018-2029)
1.3.7 Japan Anti-Nuclear Radiation Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Anti-Nuclear Radiation Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Anti-Nuclear Radiation Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Anti-Nuclear Radiation Drug Demand (2018-2029)
2.2 World Anti-Nuclear Radiation Drug Consumption by Region
2.2.1 World Anti-Nuclear Radiation Drug Consumption by Region (2018-2023)
2.2.2 World Anti-Nuclear Radiation Drug Consumption Forecast by Region (2024-2029)
2.3 United States Anti-Nuclear Radiation Drug Consumption (2018-2029)
2.4 China Anti-Nuclear Radiation Drug Consumption (2018-2029)
2.5 Europe Anti-Nuclear Radiation Drug Consumption (2018-2029)
2.6 Japan Anti-Nuclear Radiation Drug Consumption (2018-2029)
2.7 South Korea Anti-Nuclear Radiation Drug Consumption (2018-2029)
2.8 ASEAN Anti-Nuclear Radiation Drug Consumption (2018-2029)
2.9 India Anti-Nuclear Radiation Drug Consumption (2018-2029)
3 WORLD ANTI-NUCLEAR RADIATION DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Anti-Nuclear Radiation Drug Production Value by Manufacturer (2018-2023)
3.2 World Anti-Nuclear Radiation Drug Production by Manufacturer (2018-2023)
3.3 World Anti-Nuclear Radiation Drug Average Price by Manufacturer (2018-2023)
3.4 Anti-Nuclear Radiation Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Anti-Nuclear Radiation Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Anti-Nuclear Radiation Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Anti-Nuclear Radiation Drug in 2022
3.6 Anti-Nuclear Radiation Drug Market: Overall Company Footprint Analysis
3.6.1 Anti-Nuclear Radiation Drug Market: Region Footprint
3.6.2 Anti-Nuclear Radiation Drug Market: Company Product Type Footprint
3.6.3 Anti-Nuclear Radiation Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Anti-Nuclear Radiation Drug Production Value Comparison
4.1.1 United States VS China: Anti-Nuclear Radiation Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Anti-Nuclear Radiation Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Anti-Nuclear Radiation Drug Production Comparison
4.2.1 United States VS China: Anti-Nuclear Radiation Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Anti-Nuclear Radiation Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Anti-Nuclear Radiation Drug Consumption Comparison
4.3.1 United States VS China: Anti-Nuclear Radiation Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Anti-Nuclear Radiation Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Anti-Nuclear Radiation Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Anti-Nuclear Radiation Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Anti-Nuclear Radiation Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Anti-Nuclear Radiation Drug Production (2018-2023)
4.5 China Based Anti-Nuclear Radiation Drug Manufacturers and Market Share
4.5.1 China Based Anti-Nuclear Radiation Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Anti-Nuclear Radiation Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Anti-Nuclear Radiation Drug Production (2018-2023)
4.6 Rest of World Based Anti-Nuclear Radiation Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Anti-Nuclear Radiation Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Anti-Nuclear Radiation Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Potassium Iodide (KI)
5.2.2 Prussian Blue
5.2.3 Diethylenetriamine Pentaacetate (DTPA)
5.2.4 Filgrastim
5.2.5 Amifostine
5.2.6 Ex-Rad
5.3 Market Segment by Type
5.3.1 World Anti-Nuclear Radiation Drug Production by Type (2018-2029)
5.3.2 World Anti-Nuclear Radiation Drug Production Value by Type (2018-2029)
5.3.3 World Anti-Nuclear Radiation Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY SALES CHANNEL
6.1 World Anti-Nuclear Radiation Drug Market Size Overview by Sales Channel: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Sales Channel
6.2.1 Online Sales
6.2.2 Offline Sales
6.3 Market Segment by Sales Channel
6.3.1 World Anti-Nuclear Radiation Drug Production by Sales Channel (2018-2029)
6.3.2 World Anti-Nuclear Radiation Drug Production Value by Sales Channel (2018-2029)
6.3.3 World Anti-Nuclear Radiation Drug Average Price by Sales Channel (2018-2029)
7 COMPANY PROFILES
7.1 Amgen
7.1.1 Amgen Details
7.1.2 Amgen Major Business
7.1.3 Amgen Anti-Nuclear Radiation Drug Product and Services
7.1.4 Amgen Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Amgen Recent Developments/Updates
7.1.6 Amgen Competitive Strengths & Weaknesses
7.2 Humanwell Healthcare
7.2.1 Humanwell Healthcare Details
7.2.2 Humanwell Healthcare Major Business
7.2.3 Humanwell Healthcare Anti-Nuclear Radiation Drug Product and Services
7.2.4 Humanwell Healthcare Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Humanwell Healthcare Recent Developments/Updates
7.2.6 Humanwell Healthcare Competitive Strengths & Weaknesses
7.3 Jiangsu Wuzhong Pharmaceutical Group
7.3.1 Jiangsu Wuzhong Pharmaceutical Group Details
7.3.2 Jiangsu Wuzhong Pharmaceutical Group Major Business
7.3.3 Jiangsu Wuzhong Pharmaceutical Group Anti-Nuclear Radiation Drug Product and Services
7.3.4 Jiangsu Wuzhong Pharmaceutical Group Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Jiangsu Wuzhong Pharmaceutical Group Recent Developments/Updates
7.3.6 Jiangsu Wuzhong Pharmaceutical Group Competitive Strengths & Weaknesses
7.4 Hisun Pharmaceutical
7.4.1 Hisun Pharmaceutical Details
7.4.2 Hisun Pharmaceutical Major Business
7.4.3 Hisun Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
7.4.4 Hisun Pharmaceutical Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Hisun Pharmaceutical Recent Developments/Updates
7.4.6 Hisun Pharmaceutical Competitive Strengths & Weaknesses
7.5 Beijing Centergate Technologies
7.5.1 Beijing Centergate Technologies Details
7.5.2 Beijing Centergate Technologies Major Business
7.5.3 Beijing Centergate Technologies Anti-Nuclear Radiation Drug Product and Services
7.5.4 Beijing Centergate Technologies Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Beijing Centergate Technologies Recent Developments/Updates
7.5.6 Beijing Centergate Technologies Competitive Strengths & Weaknesses
7.6 Lisheng Pharmaceutical
7.6.1 Lisheng Pharmaceutical Details
7.6.2 Lisheng Pharmaceutical Major Business
7.6.3 Lisheng Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
7.6.4 Lisheng Pharmaceutical Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Lisheng Pharmaceutical Recent Developments/Updates
7.6.6 Lisheng Pharmaceutical Competitive Strengths & Weaknesses
7.7 Bayer AG
7.7.1 Bayer AG Details
7.7.2 Bayer AG Major Business
7.7.3 Bayer AG Anti-Nuclear Radiation Drug Product and Services
7.7.4 Bayer AG Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bayer AG Recent Developments/Updates
7.7.6 Bayer AG Competitive Strengths & Weaknesses
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Details
7.8.2 GlaxoSmithKline Major Business
7.8.3 GlaxoSmithKline Anti-Nuclear Radiation Drug Product and Services
7.8.4 GlaxoSmithKline Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 GlaxoSmithKline Recent Developments/Updates
7.8.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.9 Pfizer
7.9.1 Pfizer Details
7.9.2 Pfizer Major Business
7.9.3 Pfizer Anti-Nuclear Radiation Drug Product and Services
7.9.4 Pfizer Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Pfizer Recent Developments/Updates
7.9.6 Pfizer Competitive Strengths & Weaknesses
7.10 Onconova
7.10.1 Onconova Details
7.10.2 Onconova Major Business
7.10.3 Onconova Anti-Nuclear Radiation Drug Product and Services
7.10.4 Onconova Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Onconova Recent Developments/Updates
7.10.6 Onconova Competitive Strengths & Weaknesses
7.11 Novartis AG
7.11.1 Novartis AG Details
7.11.2 Novartis AG Major Business
7.11.3 Novartis AG Anti-Nuclear Radiation Drug Product and Services
7.11.4 Novartis AG Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Novartis AG Recent Developments/Updates
7.11.6 Novartis AG Competitive Strengths & Weaknesses
7.12 Teva Pharmaceuticals
7.12.1 Teva Pharmaceuticals Details
7.12.2 Teva Pharmaceuticals Major Business
7.12.3 Teva Pharmaceuticals Anti-Nuclear Radiation Drug Product and Services
7.12.4 Teva Pharmaceuticals Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Teva Pharmaceuticals Recent Developments/Updates
7.12.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.13 Clinigen
7.13.1 Clinigen Details
7.13.2 Clinigen Major Business
7.13.3 Clinigen Anti-Nuclear Radiation Drug Product and Services
7.13.4 Clinigen Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Clinigen Recent Developments/Updates
7.13.6 Clinigen Competitive Strengths & Weaknesses
7.14 Sun Pharmaceutical
7.14.1 Sun Pharmaceutical Details
7.14.2 Sun Pharmaceutical Major Business
7.14.3 Sun Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
7.14.4 Sun Pharmaceutical Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Sun Pharmaceutical Recent Developments/Updates
7.14.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
7.15 Taj Pharmaceuticals
7.15.1 Taj Pharmaceuticals Details
7.15.2 Taj Pharmaceuticals Major Business
7.15.3 Taj Pharmaceuticals Anti-Nuclear Radiation Drug Product and Services
7.15.4 Taj Pharmaceuticals Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Taj Pharmaceuticals Recent Developments/Updates
7.15.6 Taj Pharmaceuticals Competitive Strengths & Weaknesses
7.16 Merro Pharmaceutical
7.16.1 Merro Pharmaceutical Details
7.16.2 Merro Pharmaceutical Major Business
7.16.3 Merro Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
7.16.4 Merro Pharmaceutical Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Merro Pharmaceutical Recent Developments/Updates
7.16.6 Merro Pharmaceutical Competitive Strengths & Weaknesses
7.17 Luye Pharma
7.17.1 Luye Pharma Details
7.17.2 Luye Pharma Major Business
7.17.3 Luye Pharma Anti-Nuclear Radiation Drug Product and Services
7.17.4 Luye Pharma Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Luye Pharma Recent Developments/Updates
7.17.6 Luye Pharma Competitive Strengths & Weaknesses
7.18 Mingren Pharma
7.18.1 Mingren Pharma Details
7.18.2 Mingren Pharma Major Business
7.18.3 Mingren Pharma Anti-Nuclear Radiation Drug Product and Services
7.18.4 Mingren Pharma Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Mingren Pharma Recent Developments/Updates
7.18.6 Mingren Pharma Competitive Strengths & Weaknesses
7.19 Gilead Sciences
7.19.1 Gilead Sciences Details
7.19.2 Gilead Sciences Major Business
7.19.3 Gilead Sciences Anti-Nuclear Radiation Drug Product and Services
7.19.4 Gilead Sciences Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Gilead Sciences Recent Developments/Updates
7.19.6 Gilead Sciences Competitive Strengths & Weaknesses
7.20 Johnson & Johnson
7.20.1 Johnson & Johnson Details
7.20.2 Johnson & Johnson Major Business
7.20.3 Johnson & Johnson Anti-Nuclear Radiation Drug Product and Services
7.20.4 Johnson & Johnson Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Johnson & Johnson Recent Developments/Updates
7.20.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.21 Merck KGaA
7.21.1 Merck KGaA Details
7.21.2 Merck KGaA Major Business
7.21.3 Merck KGaA Anti-Nuclear Radiation Drug Product and Services
7.21.4 Merck KGaA Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 Merck KGaA Recent Developments/Updates
7.21.6 Merck KGaA Competitive Strengths & Weaknesses
7.22 Genentech Inc.
7.22.1 Genentech Inc. Details
7.22.2 Genentech Inc. Major Business
7.22.3 Genentech Inc. Anti-Nuclear Radiation Drug Product and Services
7.22.4 Genentech Inc. Anti-Nuclear Radiation Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 Genentech Inc. Recent Developments/Updates
7.22.6 Genentech Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Anti-Nuclear Radiation Drug Industry Chain
8.2 Anti-Nuclear Radiation Drug Upstream Analysis
8.2.1 Anti-Nuclear Radiation Drug Core Raw Materials
8.2.2 Main Manufacturers of Anti-Nuclear Radiation Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Anti-Nuclear Radiation Drug Production Mode
8.6 Anti-Nuclear Radiation Drug Procurement Model
8.7 Anti-Nuclear Radiation Drug Industry Sales Model and Sales Channels
8.7.1 Anti-Nuclear Radiation Drug Sales Model
8.7.2 Anti-Nuclear Radiation Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Anti-Nuclear Radiation Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Anti-Nuclear Radiation Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Anti-Nuclear Radiation Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Anti-Nuclear Radiation Drug Production Value Market Share by Region (2018-2023)
Table 5. World Anti-Nuclear Radiation Drug Production Value Market Share by Region (2024-2029)
Table 6. World Anti-Nuclear Radiation Drug Production by Region (2018-2023) & (K Units)
Table 7. World Anti-Nuclear Radiation Drug Production by Region (2024-2029) & (K Units)
Table 8. World Anti-Nuclear Radiation Drug Production Market Share by Region (2018-2023)
Table 9. World Anti-Nuclear Radiation Drug Production Market Share by Region (2024-2029)
Table 10. World Anti-Nuclear Radiation Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Anti-Nuclear Radiation Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Anti-Nuclear Radiation Drug Major Market Trends
Table 13. World Anti-Nuclear Radiation Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Anti-Nuclear Radiation Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Anti-Nuclear Radiation Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Anti-Nuclear Radiation Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Anti-Nuclear Radiation Drug Producers in 2022
Table 18. World Anti-Nuclear Radiation Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Anti-Nuclear Radiation Drug Producers in 2022
Table 20. World Anti-Nuclear Radiation Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Anti-Nuclear Radiation Drug Company Evaluation Quadrant
Table 22. World Anti-Nuclear Radiation Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Anti-Nuclear Radiation Drug Production Site of Key Manufacturer
Table 24. Anti-Nuclear Radiation Drug Market: Company Product Type Footprint
Table 25. Anti-Nuclear Radiation Drug Market: Company Product Application Footprint
Table 26. Anti-Nuclear Radiation Drug Competitive Factors
Table 27. Anti-Nuclear Radiation Drug New Entrant and Capacity Expansion Plans
Table 28. Anti-Nuclear Radiation Drug Mergers & Acquisitions Activity
Table 29. United States VS China Anti-Nuclear Radiation Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Anti-Nuclear Radiation Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Anti-Nuclear Radiation Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Anti-Nuclear Radiation Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Anti-Nuclear Radiation Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Anti-Nuclear Radiation Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Anti-Nuclear Radiation Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Anti-Nuclear Radiation Drug Production Market Share (2018-2023)
Table 37. China Based Anti-Nuclear Radiation Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Anti-Nuclear Radiation Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Anti-Nuclear Radiation Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Anti-Nuclear Radiation Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Anti-Nuclear Radiation Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Anti-Nuclear Radiation Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production Market Share (2018-2023)
Table 47. World Anti-Nuclear Radiation Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Anti-Nuclear Radiation Drug Production by Type (2018-2023) & (K Units)
Table 49. World Anti-Nuclear Radiation Drug Production by Type (2024-2029) & (K Units)
Table 50. World Anti-Nuclear Radiation Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Anti-Nuclear Radiation Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Anti-Nuclear Radiation Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Anti-Nuclear Radiation Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Anti-Nuclear Radiation Drug Production Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Table 55. World Anti-Nuclear Radiation Drug Production by Sales Channel (2018-2023) & (K Units)
Table 56. World Anti-Nuclear Radiation Drug Production by Sales Channel (2024-2029) & (K Units)
Table 57. World Anti-Nuclear Radiation Drug Production Value by Sales Channel (2018-2023) & (USD Million)
Table 58. World Anti-Nuclear Radiation Drug Production Value by Sales Channel (2024-2029) & (USD Million)
Table 59. World Anti-Nuclear Radiation Drug Average Price by Sales Channel (2018-2023) & (US$/Unit)
Table 60. World Anti-Nuclear Radiation Drug Average Price by Sales Channel (2024-2029) & (US$/Unit)
Table 61. Amgen Basic Information, Manufacturing Base and Competitors
Table 62. Amgen Major Business
Table 63. Amgen Anti-Nuclear Radiation Drug Product and Services
Table 64. Amgen Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Amgen Recent Developments/Updates
Table 66. Amgen Competitive Strengths & Weaknesses
Table 67. Humanwell Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. Humanwell Healthcare Major Business
Table 69. Humanwell Healthcare Anti-Nuclear Radiation Drug Product and Services
Table 70. Humanwell Healthcare Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Humanwell Healthcare Recent Developments/Updates
Table 72. Humanwell Healthcare Competitive Strengths & Weaknesses
Table 73. Jiangsu Wuzhong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 74. Jiangsu Wuzhong Pharmaceutical Group Major Business
Table 75. Jiangsu Wuzhong Pharmaceutical Group Anti-Nuclear Radiation Drug Product and Services
Table 76. Jiangsu Wuzhong Pharmaceutical Group Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Jiangsu Wuzhong Pharmaceutical Group Recent Developments/Updates
Table 78. Jiangsu Wuzhong Pharmaceutical Group Competitive Strengths & Weaknesses
Table 79. Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Hisun Pharmaceutical Major Business
Table 81. Hisun Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
Table 82. Hisun Pharmaceutical Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Hisun Pharmaceutical Recent Developments/Updates
Table 84. Hisun Pharmaceutical Competitive Strengths & Weaknesses
Table 85. Beijing Centergate Technologies Basic Information, Manufacturing Base and Competitors
Table 86. Beijing Centergate Technologies Major Business
Table 87. Beijing Centergate Technologies Anti-Nuclear Radiation Drug Product and Services
Table 88. Beijing Centergate Technologies Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Beijing Centergate Technologies Recent Developments/Updates
Table 90. Beijing Centergate Technologies Competitive Strengths & Weaknesses
Table 91. Lisheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Lisheng Pharmaceutical Major Business
Table 93. Lisheng Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
Table 94. Lisheng Pharmaceutical Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Lisheng Pharmaceutical Recent Developments/Updates
Table 96. Lisheng Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 98. Bayer AG Major Business
Table 99. Bayer AG Anti-Nuclear Radiation Drug Product and Services
Table 100. Bayer AG Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Bayer AG Recent Developments/Updates
Table 102. Bayer AG Competitive Strengths & Weaknesses
Table 103. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 104. GlaxoSmithKline Major Business
Table 105. GlaxoSmithKline Anti-Nuclear Radiation Drug Product and Services
Table 106. GlaxoSmithKline Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. GlaxoSmithKline Recent Developments/Updates
Table 108. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 109. Pfizer Basic Information, Manufacturing Base and Competitors
Table 110. Pfizer Major Business
Table 111. Pfizer Anti-Nuclear Radiation Drug Product and Services
Table 112. Pfizer Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Pfizer Recent Developments/Updates
Table 114. Pfizer Competitive Strengths & Weaknesses
Table 115. Onconova Basic Information, Manufacturing Base and Competitors
Table 116. Onconova Major Business
Table 117. Onconova Anti-Nuclear Radiation Drug Product and Services
Table 118. Onconova Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Onconova Recent Developments/Updates
Table 120. Onconova Competitive Strengths & Weaknesses
Table 121. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 122. Novartis AG Major Business
Table 123. Novartis AG Anti-Nuclear Radiation Drug Product and Services
Table 124. Novartis AG Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Novartis AG Recent Developments/Updates
Table 126. Novartis AG Competitive Strengths & Weaknesses
Table 127. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. Teva Pharmaceuticals Major Business
Table 129. Teva Pharmaceuticals Anti-Nuclear Radiation Drug Product and Services
Table 130. Teva Pharmaceuticals Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Teva Pharmaceuticals Recent Developments/Updates
Table 132. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 133. Clinigen Basic Information, Manufacturing Base and Competitors
Table 134. Clinigen Major Business
Table 135. Clinigen Anti-Nuclear Radiation Drug Product and Services
Table 136. Clinigen Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Clinigen Recent Developments/Updates
Table 138. Clinigen Competitive Strengths & Weaknesses
Table 139. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Sun Pharmaceutical Major Business
Table 141. Sun Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
Table 142. Sun Pharmaceutical Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Sun Pharmaceutical Recent Developments/Updates
Table 144. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 145. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Taj Pharmaceuticals Major Business
Table 147. Taj Pharmaceuticals Anti-Nuclear Radiation Drug Product and Services
Table 148. Taj Pharmaceuticals Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Taj Pharmaceuticals Recent Developments/Updates
Table 150. Taj Pharmaceuticals Competitive Strengths & Weaknesses
Table 151. Merro Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 152. Merro Pharmaceutical Major Business
Table 153. Merro Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
Table 154. Merro Pharmaceutical Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Merro Pharmaceutical Recent Developments/Updates
Table 156. Merro Pharmaceutical Competitive Strengths & Weaknesses
Table 157. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 158. Luye Pharma Major Business
Table 159. Luye Pharma Anti-Nuclear Radiation Drug Product and Services
Table 160. Luye Pharma Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Luye Pharma Recent Developments/Updates
Table 162. Luye Pharma Competitive Strengths & Weaknesses
Table 163. Mingren Pharma Basic Information, Manufacturing Base and Competitors
Table 164. Mingren Pharma Major Business
Table 165. Mingren Pharma Anti-Nuclear Radiation Drug Product and Services
Table 166. Mingren Pharma Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Mingren Pharma Recent Developments/Updates
Table 168. Mingren Pharma Competitive Strengths & Weaknesses
Table 169. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 170. Gilead Sciences Major Business
Table 171. Gilead Sciences Anti-Nuclear Radiation Drug Product and Services
Table 172. Gilead Sciences Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Gilead Sciences Recent Developments/Updates
Table 174. Gilead Sciences Competitive Strengths & Weaknesses
Table 175. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 176. Johnson & Johnson Major Business
Table 177. Johnson & Johnson Anti-Nuclear Radiation Drug Product and Services
Table 178. Johnson & Johnson Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. Johnson & Johnson Recent Developments/Updates
Table 180. Johnson & Johnson Competitive Strengths & Weaknesses
Table 181. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 182. Merck KGaA Major Business
Table 183. Merck KGaA Anti-Nuclear Radiation Drug Product and Services
Table 184. Merck KGaA Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. Merck KGaA Recent Developments/Updates
Table 186. Genentech Inc. Basic Information, Manufacturing Base and Competitors
Table 187. Genentech Inc. Major Business
Table 188. Genentech Inc. Anti-Nuclear Radiation Drug Product and Services
Table 189. Genentech Inc. Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 190. Global Key Players of Anti-Nuclear Radiation Drug Upstream (Raw Materials)
Table 191. Anti-Nuclear Radiation Drug Typical Customers
Table 192. Anti-Nuclear Radiation Drug Typical Distributors
List of Figure
Figure 1. Anti-Nuclear Radiation Drug Picture
Figure 2. World Anti-Nuclear Radiation Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Anti-Nuclear Radiation Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Anti-Nuclear Radiation Drug Production (2018-2029) & (K Units)
Figure 5. World Anti-Nuclear Radiation Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Anti-Nuclear Radiation Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Anti-Nuclear Radiation Drug Production Market Share by Region (2018-2029)
Figure 8. North America Anti-Nuclear Radiation Drug Production (2018-2029) & (K Units)
Figure 9. Europe Anti-Nuclear Radiation Drug Production (2018-2029) & (K Units)
Figure 10. China Anti-Nuclear Radiation Drug Production (2018-2029) & (K Units)
Figure 11. Japan Anti-Nuclear Radiation Drug Production (2018-2029) & (K Units)
Figure 12. Anti-Nuclear Radiation Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 15. World Anti-Nuclear Radiation Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 17. China Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 22. India Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Anti-Nuclear Radiation Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Anti-Nuclear Radiation Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Anti-Nuclear Radiation Drug Markets in 2022
Figure 26. United States VS China: Anti-Nuclear Radiation Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Anti-Nuclear Radiation Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Anti-Nuclear Radiation Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Anti-Nuclear Radiation Drug Production Market Share 2022
Figure 30. China Based Manufacturers Anti-Nuclear Radiation Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production Market Share 2022
Figure 32. World Anti-Nuclear Radiation Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Anti-Nuclear Radiation Drug Production Value Market Share by Type in 2022
Figure 34. Potassium Iodide (KI)
Figure 35. Prussian Blue
Figure 36. Diethylenetriamine Pentaacetate (DTPA)
Figure 37. Filgrastim
Figure 38. Amifostine
Figure 39. Ex-Rad
Figure 40. World Anti-Nuclear Radiation Drug Production Market Share by Type (2018-2029)
Figure 41. World Anti-Nuclear Radiation Drug Production Value Market Share by Type (2018-2029)
Figure 42. World Anti-Nuclear Radiation Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World Anti-Nuclear Radiation Drug Production Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Figure 44. World Anti-Nuclear Radiation Drug Production Value Market Share by Sales Channel in 2022
Figure 45. Online Sales
Figure 46. Offline Sales
Figure 47. World Anti-Nuclear Radiation Drug Production Market Share by Sales Channel (2018-2029)
Figure 48. World Anti-Nuclear Radiation Drug Production Value Market Share by Sales Channel (2018-2029)
Figure 49. World Anti-Nuclear Radiation Drug Average Price by Sales Channel (2018-2029) & (US$/Unit)
Figure 50. Anti-Nuclear Radiation Drug Industry Chain
Figure 51. Anti-Nuclear Radiation Drug Procurement Model
Figure 52. Anti-Nuclear Radiation Drug Sales Model
Figure 53. Anti-Nuclear Radiation Drug Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Table 1. World Anti-Nuclear Radiation Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Anti-Nuclear Radiation Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Anti-Nuclear Radiation Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Anti-Nuclear Radiation Drug Production Value Market Share by Region (2018-2023)
Table 5. World Anti-Nuclear Radiation Drug Production Value Market Share by Region (2024-2029)
Table 6. World Anti-Nuclear Radiation Drug Production by Region (2018-2023) & (K Units)
Table 7. World Anti-Nuclear Radiation Drug Production by Region (2024-2029) & (K Units)
Table 8. World Anti-Nuclear Radiation Drug Production Market Share by Region (2018-2023)
Table 9. World Anti-Nuclear Radiation Drug Production Market Share by Region (2024-2029)
Table 10. World Anti-Nuclear Radiation Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Anti-Nuclear Radiation Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Anti-Nuclear Radiation Drug Major Market Trends
Table 13. World Anti-Nuclear Radiation Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Anti-Nuclear Radiation Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Anti-Nuclear Radiation Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Anti-Nuclear Radiation Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Anti-Nuclear Radiation Drug Producers in 2022
Table 18. World Anti-Nuclear Radiation Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Anti-Nuclear Radiation Drug Producers in 2022
Table 20. World Anti-Nuclear Radiation Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Anti-Nuclear Radiation Drug Company Evaluation Quadrant
Table 22. World Anti-Nuclear Radiation Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Anti-Nuclear Radiation Drug Production Site of Key Manufacturer
Table 24. Anti-Nuclear Radiation Drug Market: Company Product Type Footprint
Table 25. Anti-Nuclear Radiation Drug Market: Company Product Application Footprint
Table 26. Anti-Nuclear Radiation Drug Competitive Factors
Table 27. Anti-Nuclear Radiation Drug New Entrant and Capacity Expansion Plans
Table 28. Anti-Nuclear Radiation Drug Mergers & Acquisitions Activity
Table 29. United States VS China Anti-Nuclear Radiation Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Anti-Nuclear Radiation Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Anti-Nuclear Radiation Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Anti-Nuclear Radiation Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Anti-Nuclear Radiation Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Anti-Nuclear Radiation Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Anti-Nuclear Radiation Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Anti-Nuclear Radiation Drug Production Market Share (2018-2023)
Table 37. China Based Anti-Nuclear Radiation Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Anti-Nuclear Radiation Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Anti-Nuclear Radiation Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Anti-Nuclear Radiation Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Anti-Nuclear Radiation Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Anti-Nuclear Radiation Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production Market Share (2018-2023)
Table 47. World Anti-Nuclear Radiation Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Anti-Nuclear Radiation Drug Production by Type (2018-2023) & (K Units)
Table 49. World Anti-Nuclear Radiation Drug Production by Type (2024-2029) & (K Units)
Table 50. World Anti-Nuclear Radiation Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Anti-Nuclear Radiation Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Anti-Nuclear Radiation Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Anti-Nuclear Radiation Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Anti-Nuclear Radiation Drug Production Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Table 55. World Anti-Nuclear Radiation Drug Production by Sales Channel (2018-2023) & (K Units)
Table 56. World Anti-Nuclear Radiation Drug Production by Sales Channel (2024-2029) & (K Units)
Table 57. World Anti-Nuclear Radiation Drug Production Value by Sales Channel (2018-2023) & (USD Million)
Table 58. World Anti-Nuclear Radiation Drug Production Value by Sales Channel (2024-2029) & (USD Million)
Table 59. World Anti-Nuclear Radiation Drug Average Price by Sales Channel (2018-2023) & (US$/Unit)
Table 60. World Anti-Nuclear Radiation Drug Average Price by Sales Channel (2024-2029) & (US$/Unit)
Table 61. Amgen Basic Information, Manufacturing Base and Competitors
Table 62. Amgen Major Business
Table 63. Amgen Anti-Nuclear Radiation Drug Product and Services
Table 64. Amgen Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Amgen Recent Developments/Updates
Table 66. Amgen Competitive Strengths & Weaknesses
Table 67. Humanwell Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. Humanwell Healthcare Major Business
Table 69. Humanwell Healthcare Anti-Nuclear Radiation Drug Product and Services
Table 70. Humanwell Healthcare Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Humanwell Healthcare Recent Developments/Updates
Table 72. Humanwell Healthcare Competitive Strengths & Weaknesses
Table 73. Jiangsu Wuzhong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 74. Jiangsu Wuzhong Pharmaceutical Group Major Business
Table 75. Jiangsu Wuzhong Pharmaceutical Group Anti-Nuclear Radiation Drug Product and Services
Table 76. Jiangsu Wuzhong Pharmaceutical Group Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Jiangsu Wuzhong Pharmaceutical Group Recent Developments/Updates
Table 78. Jiangsu Wuzhong Pharmaceutical Group Competitive Strengths & Weaknesses
Table 79. Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Hisun Pharmaceutical Major Business
Table 81. Hisun Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
Table 82. Hisun Pharmaceutical Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Hisun Pharmaceutical Recent Developments/Updates
Table 84. Hisun Pharmaceutical Competitive Strengths & Weaknesses
Table 85. Beijing Centergate Technologies Basic Information, Manufacturing Base and Competitors
Table 86. Beijing Centergate Technologies Major Business
Table 87. Beijing Centergate Technologies Anti-Nuclear Radiation Drug Product and Services
Table 88. Beijing Centergate Technologies Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Beijing Centergate Technologies Recent Developments/Updates
Table 90. Beijing Centergate Technologies Competitive Strengths & Weaknesses
Table 91. Lisheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Lisheng Pharmaceutical Major Business
Table 93. Lisheng Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
Table 94. Lisheng Pharmaceutical Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Lisheng Pharmaceutical Recent Developments/Updates
Table 96. Lisheng Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 98. Bayer AG Major Business
Table 99. Bayer AG Anti-Nuclear Radiation Drug Product and Services
Table 100. Bayer AG Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Bayer AG Recent Developments/Updates
Table 102. Bayer AG Competitive Strengths & Weaknesses
Table 103. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 104. GlaxoSmithKline Major Business
Table 105. GlaxoSmithKline Anti-Nuclear Radiation Drug Product and Services
Table 106. GlaxoSmithKline Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. GlaxoSmithKline Recent Developments/Updates
Table 108. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 109. Pfizer Basic Information, Manufacturing Base and Competitors
Table 110. Pfizer Major Business
Table 111. Pfizer Anti-Nuclear Radiation Drug Product and Services
Table 112. Pfizer Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Pfizer Recent Developments/Updates
Table 114. Pfizer Competitive Strengths & Weaknesses
Table 115. Onconova Basic Information, Manufacturing Base and Competitors
Table 116. Onconova Major Business
Table 117. Onconova Anti-Nuclear Radiation Drug Product and Services
Table 118. Onconova Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Onconova Recent Developments/Updates
Table 120. Onconova Competitive Strengths & Weaknesses
Table 121. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 122. Novartis AG Major Business
Table 123. Novartis AG Anti-Nuclear Radiation Drug Product and Services
Table 124. Novartis AG Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Novartis AG Recent Developments/Updates
Table 126. Novartis AG Competitive Strengths & Weaknesses
Table 127. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. Teva Pharmaceuticals Major Business
Table 129. Teva Pharmaceuticals Anti-Nuclear Radiation Drug Product and Services
Table 130. Teva Pharmaceuticals Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Teva Pharmaceuticals Recent Developments/Updates
Table 132. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 133. Clinigen Basic Information, Manufacturing Base and Competitors
Table 134. Clinigen Major Business
Table 135. Clinigen Anti-Nuclear Radiation Drug Product and Services
Table 136. Clinigen Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Clinigen Recent Developments/Updates
Table 138. Clinigen Competitive Strengths & Weaknesses
Table 139. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Sun Pharmaceutical Major Business
Table 141. Sun Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
Table 142. Sun Pharmaceutical Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Sun Pharmaceutical Recent Developments/Updates
Table 144. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 145. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Taj Pharmaceuticals Major Business
Table 147. Taj Pharmaceuticals Anti-Nuclear Radiation Drug Product and Services
Table 148. Taj Pharmaceuticals Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Taj Pharmaceuticals Recent Developments/Updates
Table 150. Taj Pharmaceuticals Competitive Strengths & Weaknesses
Table 151. Merro Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 152. Merro Pharmaceutical Major Business
Table 153. Merro Pharmaceutical Anti-Nuclear Radiation Drug Product and Services
Table 154. Merro Pharmaceutical Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Merro Pharmaceutical Recent Developments/Updates
Table 156. Merro Pharmaceutical Competitive Strengths & Weaknesses
Table 157. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 158. Luye Pharma Major Business
Table 159. Luye Pharma Anti-Nuclear Radiation Drug Product and Services
Table 160. Luye Pharma Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Luye Pharma Recent Developments/Updates
Table 162. Luye Pharma Competitive Strengths & Weaknesses
Table 163. Mingren Pharma Basic Information, Manufacturing Base and Competitors
Table 164. Mingren Pharma Major Business
Table 165. Mingren Pharma Anti-Nuclear Radiation Drug Product and Services
Table 166. Mingren Pharma Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Mingren Pharma Recent Developments/Updates
Table 168. Mingren Pharma Competitive Strengths & Weaknesses
Table 169. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 170. Gilead Sciences Major Business
Table 171. Gilead Sciences Anti-Nuclear Radiation Drug Product and Services
Table 172. Gilead Sciences Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Gilead Sciences Recent Developments/Updates
Table 174. Gilead Sciences Competitive Strengths & Weaknesses
Table 175. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 176. Johnson & Johnson Major Business
Table 177. Johnson & Johnson Anti-Nuclear Radiation Drug Product and Services
Table 178. Johnson & Johnson Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. Johnson & Johnson Recent Developments/Updates
Table 180. Johnson & Johnson Competitive Strengths & Weaknesses
Table 181. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 182. Merck KGaA Major Business
Table 183. Merck KGaA Anti-Nuclear Radiation Drug Product and Services
Table 184. Merck KGaA Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. Merck KGaA Recent Developments/Updates
Table 186. Genentech Inc. Basic Information, Manufacturing Base and Competitors
Table 187. Genentech Inc. Major Business
Table 188. Genentech Inc. Anti-Nuclear Radiation Drug Product and Services
Table 189. Genentech Inc. Anti-Nuclear Radiation Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 190. Global Key Players of Anti-Nuclear Radiation Drug Upstream (Raw Materials)
Table 191. Anti-Nuclear Radiation Drug Typical Customers
Table 192. Anti-Nuclear Radiation Drug Typical Distributors
List of Figure
Figure 1. Anti-Nuclear Radiation Drug Picture
Figure 2. World Anti-Nuclear Radiation Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Anti-Nuclear Radiation Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Anti-Nuclear Radiation Drug Production (2018-2029) & (K Units)
Figure 5. World Anti-Nuclear Radiation Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Anti-Nuclear Radiation Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Anti-Nuclear Radiation Drug Production Market Share by Region (2018-2029)
Figure 8. North America Anti-Nuclear Radiation Drug Production (2018-2029) & (K Units)
Figure 9. Europe Anti-Nuclear Radiation Drug Production (2018-2029) & (K Units)
Figure 10. China Anti-Nuclear Radiation Drug Production (2018-2029) & (K Units)
Figure 11. Japan Anti-Nuclear Radiation Drug Production (2018-2029) & (K Units)
Figure 12. Anti-Nuclear Radiation Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 15. World Anti-Nuclear Radiation Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 17. China Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 22. India Anti-Nuclear Radiation Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Anti-Nuclear Radiation Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Anti-Nuclear Radiation Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Anti-Nuclear Radiation Drug Markets in 2022
Figure 26. United States VS China: Anti-Nuclear Radiation Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Anti-Nuclear Radiation Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Anti-Nuclear Radiation Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Anti-Nuclear Radiation Drug Production Market Share 2022
Figure 30. China Based Manufacturers Anti-Nuclear Radiation Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Anti-Nuclear Radiation Drug Production Market Share 2022
Figure 32. World Anti-Nuclear Radiation Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Anti-Nuclear Radiation Drug Production Value Market Share by Type in 2022
Figure 34. Potassium Iodide (KI)
Figure 35. Prussian Blue
Figure 36. Diethylenetriamine Pentaacetate (DTPA)
Figure 37. Filgrastim
Figure 38. Amifostine
Figure 39. Ex-Rad
Figure 40. World Anti-Nuclear Radiation Drug Production Market Share by Type (2018-2029)
Figure 41. World Anti-Nuclear Radiation Drug Production Value Market Share by Type (2018-2029)
Figure 42. World Anti-Nuclear Radiation Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World Anti-Nuclear Radiation Drug Production Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Figure 44. World Anti-Nuclear Radiation Drug Production Value Market Share by Sales Channel in 2022
Figure 45. Online Sales
Figure 46. Offline Sales
Figure 47. World Anti-Nuclear Radiation Drug Production Market Share by Sales Channel (2018-2029)
Figure 48. World Anti-Nuclear Radiation Drug Production Value Market Share by Sales Channel (2018-2029)
Figure 49. World Anti-Nuclear Radiation Drug Average Price by Sales Channel (2018-2029) & (US$/Unit)
Figure 50. Anti-Nuclear Radiation Drug Industry Chain
Figure 51. Anti-Nuclear Radiation Drug Procurement Model
Figure 52. Anti-Nuclear Radiation Drug Sales Model
Figure 53. Anti-Nuclear Radiation Drug Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
